SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000891618-99-001221
Filing Date
1999-03-30
Accepted
1999-03-30 00:00:00
Documents
12
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 FOR PERIOD ENDED 12/31/98 10-K405 261635
2 STOCK PURCHASE AGREEMENT W/SMITHKLINE BEECHAM EX-10.21 33031
3 SECURITY AGREEMENT W/ SMITHKLINE BEECHAM EX-10.22 45974
4 GRANT OF SECURITY INTEREST W/ SMITHKLINE BEECHAM EX-10.23 6684
5 LOAN AGREEMENT W/ SMITHKLINE BEECHAM EX-10.24 65068
6 COLLABORATION AGREEMENT / SMITHKLINE BEECHAM EX-10.25 482002
7 SUPPLY AGREEMENT W/BOEHRINGER INGELHEIM PHARMA KG EX-10.26 78446
8 1ST AMENDMENT TO LEASE AGREEMENT W/HMS GATEWAY EX-10.27 80964
9 AMEND #1 TO COLLABORATION AGREEMENT W/SMITHKLINE EX-10.28 3064
10 LOAN & SECURITY AGRREMENT W/ SILICON VALLEY BANK EX-10.29 126068
11 CONSENT OF ERNST & YOUNG LLP EX-23.1 735
12 FINANCIAL DATA SCHEDULE EX-27.1 2055
  Complete submission text file 0000891618-99-001221.txt   1188472
Mailing Address 550 CALIFORNIA AVE STE 200 PALO ALTO CA 94306
Business Address 550 CALIFORNIA AVE STE 200 PALO ALTO CA 94306 4158427300
COULTER PHARMACEUTICALS INC (Filer) CIK: 0000942416 (see all company filings)

IRS No.: 943219075 | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-21905 | Film No.: 99576977
SIC: 2834 Pharmaceutical Preparations